Today lecture in UVAS lhr campus on future scop of mlt,Training of MLT,mLT registration AHP council,PMLA role for AHP registration.significance of PGGN in Pakistan…..in coming future…….3hr lecture with Answer question section with final year mlt,mphil students,2 hr fruitful meeting with prof Dr Tahir yaqoob Directir microbiology. Uvas ..detail discussion on PMLA role for AHP and On PHC topic………….
The Pakistan Medical Laboratory Association (PMLA) represents medical laboratory professionals in Pakistan. The association aims to promote the highest standards of laboratory medicine and to support the development of the laboratory profession in the country.
One of the key objectives of the PMLA is to advocate for the registration and regulation of Allied Health Professionals (AHPs) and paramedics in Pakistan.
By advocating for the registration and regulation of AHPs and paramedics, the PMLA aims to ensure that these professionals meet certain standards of education, training, and practice. This would help to ensure that AHPs and paramedics are competent and qualified to provide high-quality healthcare services to patients in Pakistan.
Moreover, the registration and regulation of AHPs and paramedics would also help to protect the public from unqualified and untrained individuals who may pose a risk to patient safety. By establishing a regulatory framework for AHPs and paramedics.
PMLA & PGGN
The cooperation between the Pakistan Medical Laboratory Association (PMLA) and the Pakistan Globin Gene Network (PGGN) in Pakistan could have several potential benefits for the healthcare system in the country.
There are several ways in which the PMLA and PGGN could collaborate to advance their respective goals. For example, the PMLA could provide support and resources to PGGN researchers in their efforts to collect and analyze blood samples from patients with hemoglobin disorders. In turn, the PGGN could provide training and educational opportunities to PMLA members on the latest advances in hematology and molecular genetics.
Additionally, the PMLA and PGGN could work together to raise awareness about the importance of early diagnosis and management of hemoglobin disorders in Pakistan. This could involve developing public education campaigns, organizing seminars and workshops, and partnering with other stakeholders, such as patient advocacy groups and healthcare providers.
Overall, the cooperation between the PMLA and PGGN has the potential to benefit patients with hemoglobin disorders in Pakistan, as well as the broader healthcare system in the country. By working together, these two organizations can leverage their respective strengths and expertise to improve the quality of care and outcomes for patients with these conditions.
